This sub-$10 pharma stock is attempting a bullish breakout, according to the charts
CNBC: Investing
JULY 2, 2025
The stock popped up in a routine review of S & P 500 components, where we constantly look for potential basing formations or bullish patterns — whether near highs or attempting to bottom after long periods of underperformance. That's the blueprint VTRS bulls will be watching for again now.
Let's personalize your content